Get ready to energize your life?
Top Offers Only Today
Support your health and step-up your mental focus
post in: Products, Beauty, Health Date:08 Oct 2017, 11:29 views:2888
The scale of the problem, between 100 and 150 million people around the globe - roughly the equivalent of the population of the Russian Federation - suffer from asthma and this number is rising. World-wide, deaths from this condition have reached over 180,000 annually. Around 8 of the Swiss population suffers from asthma as against only 2 some 25-30 years ago.
In Germany, there are an estimated 4 million asthmatics. In Western Europe as a whole, asthma has doubled in ten years, according to the UCB Institute of Allergy in Belgium.
In the United States, the number of asthmatics has leapt by over 60 since the early 1980s and deaths have doubled to 5,000 a year. There are about 3 million asthmatics in Japan of whom 7 have severe and 30 have moderate asthma.
In Australia, one child in six under the age of 16 is affected. Asthma is not just a public health problem for developed countries. In developing countries, however, the incidence of the disease varies greatly.
India has an estimated 15-20 million asthmatics. In the Western Pacific Region of WHO, the incidence varies from over 50 among children in the Caroline Islands to virtually zero in Papua New Guinea. In Brazil, Costa Rica, Panama, Peru and Uruguay, prevalence of asthma symptoms katy in children varies from 20.
In Kenya, it approaches.
In India, rough estimates indicate a prevalence of between 10 and 15 in 5-11 year old children. The human and economic burden, mortality due to asthma is not comparable in size to the day-to-day effects of the disease. Although largely avoidable, asthma tends to occur in epidemics and affects young people.
The human and economic burden associated with this condition is severe. The costs of asthma to society could be reduced to a large extent through concerted international and national action.
World-wide, the economic costs associated with asthma are estimated to exceed those of TB and HIV/aids combined.
In the United States, for example, annual asthma care costs (direct and indirect) exceed US6 billion.